Drug Type Fusion protein |
Synonyms ASKG 915, ASKG915 |
Target |
Mechanism Interleukin-15 receptors modulators(Interleukin-15 receptors modulators), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 1 | US | 02 Aug 2023 | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 02 Aug 2023 |